Novartis licenses Abogen's mRNA-encoded T-cell engager for autoimmune disease, raising scale-up questions for mRNA-lipid nanoparticle manufacturing.
|Articles|October 2, 2014
- Pharmaceutical Technology-10-02-2014
- Volume 38
- Issue 10
Ross Agitated Vessel Includes Silicone Heating Blankets
The Ross VSL-50 is a portable 50-gallon agitated vessel with silicone heating blankets and temperature sensors fabricated in stainless steel 316 and designed for atmospheric operation.
The Ross VSL-50 is a portable 50-gallon agitated vessel with silicone heating blankets and temperature sensors fabricated in stainless steel 316 and designed for atmospheric operation.
The VSL-50’s propeller agitator has a half HP inverter-duty motor and is controlled by a NEMA 4X stainless-steel panel that includes an E-Stop mushroom head, cycle timer, digital heater temperature controller, and a high-temperature alarm.
Ross Agitated Vessels are customizable and can be equipped with sight/charge ports and process connections.
Charles Ross & Son Company
Articles in this issue
about 12 years ago
Biopharma Manufacturers Respond to Ebola Crisisabout 12 years ago
Determining Facility Mold Infectionabout 12 years ago
Romaco Kilian's Tablet Press Introduces Continuous Weight Controlabout 12 years ago
GEA Pharma Systems Valves Contain Powdersabout 12 years ago
Packaging Addresses Cold-Chain Requirementsabout 12 years ago
Fluorination Remains Key Challenge in API Synthesisabout 12 years ago
Fette Tablet Press Designed for High Productionabout 12 years ago
Marrying Big Data with Personalized Medicineabout 12 years ago
Bolstering Graduate Education and Research ProgramsRelated to this article
Ron Scarboro, Azurity Pharmaceuticals, explains why real-world usability belongs at product definition and how post-launch feedback should guide drug formulation.
Ronald Piervincenzi, USP, explains why drug supply resilience needs a system approach, from procurement benchmarks to regulatory capacity building.
Gene manufacturing platforms, patient-centric formulations, contract services, packaging innovations, and sterile filling lines are in the spotlight at CPHI Milan 2026.
Ronald Piervincenzi, USP, explains why drug supply resilience needs a system approach, from procurement benchmarks to regulatory capacity building.
Richard Jaenisch weighs how FDA's new NAM rule could reshape preclinical testing and what CMC teams should do now, on Manufacturing Intelligence.
In a preview of their panel discussion at AAPS PharmSci 360 2026, Alfred Rumondor, PhD, AbbVie, and Swita Singh, PhD, Bristol Myers Squibb, discuss the implementation of risk-based approaches for CMC.
Ronald Piervincenzi, USP, urges drugmakers and purchasers to act on supply chain resilience to curb drug shortages and shape better policy.